Atlas Trials

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

Clinical trial NCT01513863 · COMPLETED

Trial details

NCT number
NCT01513863
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rosacea
Start date
2011-08-01
Primary completion
2012-06-01
Enrollment
602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.